This shift is expected to accelerate following the FDA’s recent label expansion of Novo Nordisk’s Ozempic® to include CKD benefits, reinforcing the drug’s growing role in renal care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback